---
title: "Impact of mass oral cholera vaccination in Uvira, DRC: surveillance-based counterfactual analysis"
id: "medrxiv-13-impact-of-mass-oral-cholera-vaccination-in-an-endemic-area-of-the-democratic"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-13-impact-of-mass-oral-cholera-vaccination-in-an-endemic-area-of-the-democratic"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.17.26363298v1?rss=1"
published_at: "2026-09-20T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Impact of mass oral cholera vaccination in Uvira, DRC: surveillance-based counterfactual analysis
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-13-impact-of-mass-oral-cholera-vaccination-in-an-endemic-area-of-the-democratic
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.17.26363298v1?rss=1)
- **Published At:** 2026-09-20T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This study estimated the population-level impact of a 2020 **mass oral cholera vaccine (OCV)** campaign in Uvira, Democratic Republic of the Congo, using enhanced surveillance and counterfactual transmission models. - Enhanced cholera surveillance ran from January 2017 to December 2023 at the two official cholera treatment facilities in Uvira and included systematic rapid diagnostic testing. - Repeated representative population surveys captured healthcare-seeking behavior, vaccination coverage, population mobility, and antibody profiles to estimate seroincidence. - A Bayesian framework integrated surveillance, survey, diagnostic, and serologic data into an ensemble of mechanistic cholera transmission models that accounted for time-varying transmissibility, immunity dynamics, and loss of vaccine-derived protection due to population turnover. - The 2020 campaign achieved 66% coverage with at least one dose of **Euvichol Plus**. - Ensemble counterfactual modeling estimated the 2020 campaign averted 56% (95% Credible Interval [CrI] 34–81) of infections and deaths over the following three years. - This impact corresponds to a median of 2,350 (95% CrI 890–8,960) averted facility-attended cases and 44 (95% CrI 16–150) averted facility and community deaths. - Modeling suggested vaccinating the entire eligible population would have averted 64% (median, 95% CrI 43–87) of cases and deaths; lower population turnover would increase impact (71% median, 95% CrI 52–90 at half the turnover). - The authors highlight that imperfect coverage, population turnover, and high transmission rates limited the achievable benefits of OCV in this endemic setting. - The study concludes that sustained cholera control in Uvira requires multisectoral interventions including improvements in water and sanitation and managing expectations about vaccine program outcomes. - Funding sources included Gavi and the Wellcome Trust; ethics approvals and participant consent were obtained from relevant institutional review boards.
## Clinical Analysis & Structured Key Points
Impact of mass oral cholera vaccination in an endemic area of the Democratic Republic of the Congo: a surveillance-based counterfactual modeling analysis | medRxiv Skip to main content Impact of mass oral cholera vaccination in an endemic area of the Democratic Republic of the Congo: a surveillance-based counterfactual modeling analysis View ORCID Profile Javier Perez-Saez , View ORCID Profile Espoir Bwenge Malembaka , View ORCID Profile Judith A Bouman , View ORCID Profile Patrick Musole Bugeme , View ORCID Profile Chloe Hutchins , Jules Jackson , Esperance Tshiwedi-Tsilabia , View ORCID Profile Juan Dent Hulse , Jaime Mufitini Saidi , Baron Bashige Rumedeka , Moise Itongwa , Oliver Cumming , Esther German , Jean-Claude Kulondwa , Amy B Dighe , View ORCID Profile Christy Clutter , View ORCID Profile Justin Thomas Lessler , View ORCID Profile Daniel T Leung , View ORCID Profile Karin Gallandat , View ORCID Profile Elizabeth C Lee , View ORCID Profile Placide Welo Okitayemba , View ORCID Profile Daniel Mukadi-Bamuleka , View ORCID Profile Jacqueline Knee , View ORCID Profile Andrew S Azman doi: https://doi.org/10.64898/2026.09.17.26363298 Javier Perez-Saez 1 Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Javier Perez-Saez Espoir Bwenge Malembaka 1 Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Espoir Bwenge Malembaka Judith A Bouman 2 Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Judith A Bouman Patrick Musole Bugeme 1 Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Patrick Musole Bugeme Chloe Hutchins 3 Department of Disease Control, London School of Hygiene and Tropical Medicine, London, United Kingdom; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Chloe Hutchins Jules Jackson 4 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Esperance Tshiwedi-Tsilabia 5 Rodolphe Merieux Institut National de Recherche Biomedicale Goma, Goma, Democratic Republic of the Congo; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Juan Dent Hulse 4 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Juan Dent Hulse Jaime Mufitini Saidi 6 Zone de Sante d'Uvira, Ministere de la Sante Publique, Hygiene et Prevention, Uvira, Democratic Republic of the Congo; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Baron Bashige Rumedeka 7 Oxfam International, Uvira, Democratic Republic of the Congo; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Moise Itongwa 7 Oxfam International, Uvira, Democratic Republic of the Congo; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Oliver Cumming 3 Department of Disease Control, London School of Hygiene and Tropical Medicine, London, United Kingdom; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Esther German 3 Department of Disease Control, London School of Hygiene and Tropical Medicine, London, United Kingdom; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jean-Claude Kulondwa 8 Division Provinciale de la Sante du Sud-Kivu, Ministere de la Sante Publique, Hygiene et Prevention, Bukavu, Democratic Republic of the Congo; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Amy B Dighe 4 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Christy Clutter 9 Division of Infectious Diseases and Division of Microbiology and Immunology, University of Utah School of Medicine, Salt Lake City, Utah, USA; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Christy Clutter Justin Thomas Lessler 10 Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Justin Thomas Lessler Daniel T Leung 9 Division of Infectious Diseases and Division of Microbiology and Immunology, University of Utah School of Medicine, Salt Lake City, Utah, USA; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Daniel T Leung Karin Gallandat 11 Department of Sanitation, Water and Solid Waste for Development, Swiss Federal Institute of Aquatic Science and Technology (Eawag), Duebendorf, Switzerland; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Karin Gallandat Elizabeth C Lee 1 Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Elizabeth C Lee Placide Welo Okitayemba 12 Programme National d'Elimination de Cholera et de lutte contre les autres Maladies Diarrheiques (PNECHOL-MD), Ministere de la Sante Publique, Hygiene et Prevention, Kinshasa, Democratic Republic of the Congo Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Placide Welo Okitayemba Daniel Mukadi-Bamuleka 5 Rodolphe Merieux Institut National de Recherche Biomedicale Goma, Goma, Democratic Republic of the Congo; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Daniel Mukadi-Bamuleka Jacqueline Knee 3 Department of Disease Control, London School of Hygiene and Tropical Medicine, London, United Kingdom; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Jacqueline Knee Andrew S Azman 1 Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Andrew S Azman For correspondence: andrew.azman{at}unige.ch Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Abstract Background Oral cholera vaccines (OCVs) are a key component of cholera control recommended in cholera-endemic areas. Yet evidence of their population-level impact is limited, especially in Africa where most cholera deaths occur. Here, we estimate the impact of mass administration of OCVs in the cholera-endemic city of Uvira, Democratic Republic of the Congo. Methods We conducted enhanced cholera surveillance at the two official cholera treatment facilities in Uvira between Jan 2017 and Dec 2023, centered around a mass vaccination campaign that achieved 66% coverage with at least one dose of Euvichol Plus vaccine in 2020. We combined systematic rapid diagnostic case testing with repeated, representative population surveys capturing healthcare-seeking behavior, vaccination, population mobility, and antibody profiles to estimate seroincidence. We developed a Bayesian framework that integrates these data into an ensemble of mechanistic cholera transmission models that account for time-varying transmissibility, realistic immunity dynamics and loss of vaccination coverage to population turnover. OCV impact was assessed through ensemble counterfactual modeling of alternative vaccination scenarios. Findings We estimate that the 2020 mass vaccination averted 56% (95% Credible Interval: 34-81) of infections and deaths over the subsequent three years. This corresponds to 2,350 (median, 95% CrI: 890-8,960) averted facility-attended cases, and 44 (median, 95% CrI: 16-150) averted facility and community deaths. Vaccination of the entire eligible population of Uvira would have averted 64% (median, 95% CrI: 43-87) of cases and deaths, with a negative but limited influence of vaccine coverage loss because of population turnover (71% median, 95% CrI: 52-90 at half the population turnover). Interpretation Although mass vaccination averted a significant fraction of cholera cases that would have otherwise occurred in this endemic setting, imperfect coverage, population turnover, and high transmission rates contributed in offsetting the larger potential benefits of OCV. Successful cholera control in Uvira hinges on multisectorial approaches including provision of safe water and sanitation. Setting and communicating realistic expectations for mass vaccination programs in highly endemic areas is critical for maintaining confidence in the current generation of OCVs. Funding Gavi (M&E 9166 09 20 A16) and the Wellcome Trust (221688/Z/20/Z). Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The study was approved by the ethics committee at the Johns Hopkins Bloomberg School of Public Health (IRB00015785), the London School of Hygiene and Tropical Medicine (25365) and the University of Kinshasa School of Public Health (ESP/ CE/65/2021). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability Data and code needed to reproduce primary analyses are available at https://github.com/GenevaIDD/uvira-ocv-impact. https://github.com/GenevaIDD/uvira-ocv-impact Funder Information Declared Gavi, https://ror.org/0141yg674 , M&E 9166 09 20 A16 Wellcome Trust, https://ror.org/029chgv08 , 221688/Z/20/Z Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license . Back to top Previous Next Posted September 20, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Impact of mass oral cholera vaccination in an endemic area of the Democratic Republic of the Congo: a surveillance-based counterfactual modeling analysis Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Impact of mass oral cholera vaccination in an endemic area of the Democratic Republic of the Congo: a surveillance-based counterfactual modeling analysis Javier Perez-Saez , Espoir Bwenge Malembaka , Judith A Bouman , Patrick Musole Bugeme , Chloe Hutchins , Jules Jackson , Esperance Tshiwedi-Tsilabia , Juan Dent Hulse , Jaime Mufitini Saidi , Baron Bashige Rumedeka , Moise Itongwa , Oliver Cumming , Esther German , Jean-Claude Kulondwa , Amy B Dighe , Christy Clutter , Justin Thomas Lessler , Daniel T Leung , Karin Gallandat , Elizabeth C Lee , Placide Welo Okitayemba , Daniel Mukadi-Bamuleka , Jacqueline Knee , Andrew S Azman medRxiv 2026.09.17.26363298; doi: https://doi.org/10.64898/2026.09.17.26363298 Share This Article: Copy Citation Tools Impact of mass oral cholera vaccination in an endemic area of the Democratic Republic of the Congo: a surveillance-based counterfactual modeling analysis Javier Perez-Saez , Espoir Bwenge Malembaka , Judith A Bouman , Patrick Musole Bugeme , Chloe Hutchins , Jules Jackson , Esperance Tshiwedi-Tsilabia , Juan Dent Hulse , Jaime Mufitini Saidi , Baron Bashige Rumedeka , Moise Itongwa , Oliver Cumming , Esther German , Jean-Claude Kulondwa , Amy B Dighe , Christy Clutter , Justin Thomas Lessler , Daniel T Leung , Karin Gallandat , Elizabeth C Lee , Placide Welo Okitayemba , Daniel Mukadi-Bamuleka , Jacqueline Knee , Andrew S Azman medRxiv 2026.09.17.26363298; doi: https://doi.org/10.64898/2026.09.17.26363298 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Epidemiology Subject Areas All Articles Addiction Medicine (619) Allergy and Immunology (903) Anesthesia (334) Cardiovascular Medicine (4828) Dentistry and Oral Medicine (479) Dermatology (419) Emergency Medicine (651) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1633) Epidemiology (15974) Forensic Medicine (33) Gastroenterology (1206) Genetic and Genomic Medicine (7065) Geriatric Medicine (734) Health Economics (1066) Health Informatics (5060) Health Policy (1437) Health Systems and Quality Improvement (1775) Hematology (587) HIV/AIDS (1347) Infectious Diseases (except HIV/AIDS) (16307) Intensive Care and Critical Care Medicine (1174) Medical Education (671) Medical Ethics (155) Nephrology (727) Neurology (7291) Nursing (368) Nutrition (1084) Obstetrics and Gynecology (1243) Occupational and Environmental Health (1005) Oncology (3614) Ophthalmology (1055) Orthopedics (398) Otolaryngology (457) Pain Medicine (472) Palliative Medicine (139) Pathology (709) Pediatrics (1805) Pharmacology and Therapeutics (739) Primary Care Research (768) Psychiatry and Clinical Psychology (5919) Public and Global Health (9770) Radiology and Imaging (2432) Rehabilitation Medicine and Physical Therapy (1456) Respiratory Medicine (1250) Rheumatology (642) Sexual and Reproductive Health (773) Sports Medicine (579) Surgery (782) Toxicology (107) Transplantation (305) Urology (293)
## Related Clinical Research

- [Understanding Parasitic Identification in Delusional Parasitosis](https://medichelpline.com/clinical-feed/plos-one-21-bridging-perception-and-reality-parasitic-identification-in-delusional.md)
- [Community-based mpox seroprevalence study in Manitoba and Alberta: evidence of undocumented exposu](https://medichelpline.com/clinical-feed/medrxiv-17-community-based-assessment-of-mpox-seroprevalence-and-undocumented-exposures-in.md)
- [Microbiome Profiling Identifies Prognostic Heterogeneity in Staphylococcus aureus Pneumonia](https://medichelpline.com/clinical-feed/medrxiv-18-microbiome-profiling-reveals-prognostic-heterogeneity-in-staphylococcus-aureus.md)
- [Kennedy renews attacks on vaccines at Children’s Health Defense conference](https://medichelpline.com/clinical-feed/stat-news-1-kennedy-renews-attacks-on-vaccines-at-children-s-health-defense-conference.md)
- [Study says purer fentanyl won’t by itself explain U.S. overdose death decline](https://medichelpline.com/clinical-feed/stat-news-2-purer-fentanyl-won-t-solve-the-u-s-overdose-death-crisis-study-says.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.